Tricol

Quick links to important sections

Tricol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tricol

Property Description
Active Ingredients Cyproheptadine, Tricholine Citrate, Sorbitol
Form Oral Solution / Syrup
Pharmacological Class Appetite Stimulant (Primary), Bile Acid Binding Agent
Common Use Nutritional support for poor appetite and deficiencies
Origin Combination of Synthetic and Derived components

Tricol: Identity, Type, and Pharmacological Class

Tricol is defined as a prescription-only, combination drug formulated as an oral solution or syrup, which includes three distinct active compounds. Its primary classification establishes it as an Appetite Stimulant and a medication intended to provide metabolic support, specifically related to liver function. This multi-mechanism approach, integrating a systemic appetite trigger with metabolic aid, is used in comprehensive nutritional management. The key appetite-enhancing component, Cyproheptadine, is a first-generation antihistamine with established antiserotonergic activity. This means the medicine helps to stimulate the feeling of hunger by adjusting certain chemical signals in the body.


Unique Combination and General Purpose

The core of the drug’s identity lies in the synergistic activities of Cyproheptadine, Tricholine Citrate, and Sorbitol. The Tricholine Citrate component is incorporated for its capacity as a bile acid binding agent, which is utilized for supporting the liver’s metabolism of fats and cholesterol. This indicates that the medicine supports the liver's ability to process fats efficiently, differentiating it from stimulants that only target appetite. Sorbitol is utilized both in the aqueous solution base and for its functional role as an osmotic agent, providing gentle digestive comfort. The general purpose of the Tricol formulation is to enhance appetite while simultaneously supporting essential metabolic processes, thereby providing nutritional support in common scenarios involving poor appetite and associated nutritional deficiencies.

Regulatory References

  1. NIH LiverTox, Cyproheptadine

What side effects are possible with Tricol?

Possible Side Effects and Safety Information

Tricol (often a combination product containing an antihistamine, a decongestant, and a pain reliever) is generally well-tolerated when used as directed. However, like all medications, it can cause side effects. Awareness of these is crucial for safe use.

Common Side Effects

Side effects are often mild and may subside as your body adjusts to the medication. These are typically related to the individual components of Tricol. For instance, the antihistamine component can cause central nervous system effects, and the decongestant can affect the cardiovascular system.

System Affected Potential Side Effects
Central Nervous System Drowsiness, dizziness, dry mouth, blurred vision, nervousness, insomnia
Cardiovascular Increased heart rate (tachycardia), palpitations, elevated blood pressure
Gastrointestinal Nausea, vomiting, stomach upset

Serious Side Effects

While rare, certain side effects require immediate medical attention. If you experience signs of an allergic reaction (e.g., rash, itching, severe dizziness, trouble breathing) or severe cardiovascular events (e.g., chest pain, severe or persistent high blood pressure), discontinue use and seek emergency care. Overdose, particularly due to the pain reliever component, can cause severe liver damage and is a medical emergency.

Contraindications and Safety

Tricol is typically contraindicated in patients with a known hypersensitivity to any of its components. Due to the decongestant, it should be used with caution, or avoided, in individuals with severe high blood pressure, heart disease, or narrow-angle glaucoma. Due to the pain reliever, it should be used cautiously in those with liver or kidney impairment. Consult a healthcare professional before use, especially if taking other medications, to check for potential drug interactions.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Tricol, derived from regulatory prescribing information, focuses on the systemic effects of the active ingredient, Cyproheptadine. Immediate medical attention or contact with emergency services is required if an overdose is suspected, due to the potential for life-threatening complications.

Overdose manifestations are primarily described by regulatory authorities as related to Anticholinergic Toxicity and Central Nervous System (CNS) effects. These can include both CNS depression (extreme sedation, stupor, or coma) and paradoxical CNS excitation (agitation, hallucinations, or convulsions). Peripheral signs such as dilated pupils and dry skin are also documented clinical manifestations.

Severe outcomes officially listed include life-threatening cardiorespiratory instability, such as profound changes in blood pressure, heart rate irregularities (tachycardia), and progression to cardiac or respiratory arrest. Population-specific warnings note an increased severity of CNS excitation in pediatric patients and heightened risks of severe hypotension and sedation in the elderly.

Regulatory documentation confirms that no specific antidote is known for this overdose. Management is constrained to symptomatic and supportive treatment, involving procedures like gastric lavage, administration of activated charcoal, continuous monitoring of vital signs, and ECG observation.

Therapeutic Uses of Tricol

What Tricol Treats: Main Uses and Benefits

Tricol is considered relevant for managing symptomatic patterns associated with insufficient dietary intake and resulting deficiencies. Its primary component, Cyproheptadine, is a component that may be applied in addressing appetite loss, contributing to symptomatic relief.


Key Therapeutic Focus

This medication is commonly used to help with the challenging symptom of loss of appetite (anorexia) and poor desire to eat. It supports appetite stimulation, which may assist with managing symptoms related to nutritional deficiencies and contributing to healthy weight management. Its therapeutic relevance is considered relevant in conditions characterized by persistent undernutrition, unintentional weight loss, and liver-associated metabolic imbalances.


Assisting Metabolic Balance

Beyond its primary role, the combination formulation is relevant in contexts involving heightened systemic burden, providing supportive management for liver-associated metabolic imbalances and contributing to improved general well-being during symptomatic phases. It is often used during phases when symptoms become more noticeable, such as long-term treatments or recovery from chronic illness.


Quick Fact: Supportive Management for Chronic Appetite Loss and Nutritional Deficiency

Regulatory References

  1. NIH LiverTox Overview of Cyproheptadine

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Tricol — Official Regulatory Information

Eligibility scope

Populations for whom use is allowed (as stated in label):

  • Adults and pediatric patients aged two years and older.

Populations for whom use is not recommended (if applicable):

  • Use is limited or requires caution in patients with renal or hepatic impairment, hyperthyroidism, cardiovascular disease, or history of bronchial asthma.

Populations for whom use is contraindicated:

  • Newborn or premature infants, nursing mothers, and elderly or debilitated patients.
  • Patients with Hypersensitivity to any component or those receiving Monoamine Oxidase Inhibitor (MAOI) therapy.

Age-related eligibility rules:

  • Newborn or premature infants and elderly/debilitated patients are contraindicated populations.
  • Safety and effectiveness have not been established for children under two years of age.

Condition-specific eligibility rules (Contraindications):

  • The medicine is contraindicated in patients with angle-closure glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, bladder neck obstruction, or pyloroduodenal obstruction.

Pregnancy and lactation eligibility status (if explicitly documented):

  • Pregnancy: Use only if clearly needed.
  • Lactation: Contraindicated in nursing mothers.

Eligibility classifications (high-level)

Eligibility severity classification (as defined in official documents): Contraindicated, Use with caution, and Safety and effectiveness not established.

Resulting eligibility structure

Official regulatory documents define a large population that must not use this medicine due to a combination of physiological status and co-existing medical conditions, such as obstructive urinary and gastrointestinal tract diseases. Eligibility is generally established for adults and children ge 2 years whose health profile does not include these specific contraindications or conditions that require mandatory caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interaction information for Tricol, which is primarily driven by the active compound Cyproheptadine, as stated in government regulatory documents.


Formal Interaction Restrictions

Co-administration with Monoamine Oxidase (MAO) Inhibitors (such as Isocarboxazid, Phenelzine, or Selegiline) is contraindicated, as these agents are documented to prolong and intensify the anticholinergic effects of the medicine. The combination with Metyrapone is also contraindicated because the active substance is known to decrease its therapeutic effects. These prohibitions are mandated in regulatory labeling based on the risks of interaction.


Pharmacodynamic and Substance Interactions

Regulatory documents describe an additive effect when Tricol is co-administered with alcohol and other Central Nervous System (CNS) depressants, including sedatives, hypnotics, and tranquilizers. This interaction may result in enhanced CNS depression, such as increased drowsiness. Regarding ingestion, the official label notes no known interactions with common food or drinks.


Population-Specific Constraints

The medicine is contraindicated for use in elderly and debilitated patients due to the higher susceptibility to intensified effects, including dizziness and hypotension, which are heightened by drug interactions. Use is also formally restricted in newborn or premature infants.

Mechanism of Action

How Tricol Works

Affects Receptor-Mediated Signaling

Tricol's primary action involves the alteration of key receptors associated with heightened physiological responses. Engagement at these sites initiates signaling sequences that result in the downregulation of activity or modification of signaling patterns within targeted systems. The drug's affinity for these specific molecular targets dictates its cell-level effects.


Involves Enzyme-Driven Pathways

In addition to receptor modulation, Tricol influences specific early molecular steps governed by distinct enzymatic patterns. This interaction results in the altered concentration or turnover of key mediators within the cell. The subsequent modification of complex signaling cascades contributes to the overall effect profile by engaging regulatory mechanisms within cellular pathways.


Physiological Adjustments

Through the combined action of receptor binding and enzyme modification, Tricol exerts its pharmacodynamic effect, leading to a series of observable physiological adjustments at the system level. This modification of processes driven by distinct signaling patterns is the mechanism that determines the drug's activity profile.

Dosage and Administration Information

The administration of Tricol oral solution is structured around official guidelines, requiring adherence to principles of precise measurement and dose individualization. This medication is designated for the oral route only. The formulation's primary dosed component, Cyproheptadine, is typically standardized at 2 mg per 5 mL of the syrup.

Dosing and Schedule

Usage involves an individualized approach where the dosage is determined and adjusted based on patient need and response. For adults, the starting regimen often involves 4 mg of the primary active component, administered in divided doses three times daily (TID). The common maintenance dosage generally ranges from 12 mg to 16 mg per day, and the maximum daily intake is restricted to 0.5 mg/kg of body weight. The medicine offers flexibility in administration timing, as it may be taken with or without food.

Administration Requirements

Proper use mandates that the oral solution be shaken well immediately prior to each dose. To ensure dosing accuracy within the prescribed limits, the measured volume must be drawn using a specialized medical measuring device (such as an oral syringe or measuring cup), rather than household spoons.

Population-Specific Guidance

Official labels define specific parameters for use in different age groups and clinical contexts. For children aged 2 to 6 years, the maximum daily dose is restricted to 12 mg, while for those aged 7 to 14 years, the limit is 16 mg per day. Additionally, reduced starting doses are advised for older adults, and caution is warranted for patients with renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tricol

Research evidence for Tricol is organized around the described pharmacological properties of its key components, which include Cyproheptadine and Tricholine Citrate. The available data primarily comes from studies exploring short-term symptom changes and patient-reported outcomes.


Evidence for use in Chronic Appetite Loss and Undernutrition

Research examining the appetite-stimulating component of Tricol largely consists of Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews which explored outcomes related to poor appetite (anorexia) and associated undernutrition.

These studies primarily examined subjects experiencing fluctuating or unstable symptoms of appetite loss. Research examined outcomes related to physical discomfort and nutritional status, such as weight gain measured in kilograms, changes in Body Mass Index (BMI), and how patients or their caregivers described their experience via appetite scores.

Findings describe patterns observed in these studies, where certain trials reported measurements of short-term weight change and documented shifts in patient-reported appetite scores, and described these findings as observed primarily in studies of pediatric patients. However, the evidence derived from settings with varying symptom burdens also highlights that findings were mixed across different study populations. Research provides insight into short-term changes, but study results reflect the specific conditions under which they were conducted.


Evidence for Supportive Metabolic and Liver Balance

The supportive role of the medicine was studied for the actions of Tricholine Citrate, which research describes as a bile acid binding agent. Studies explored how this component can be associated with fat metabolism and systemic or functional imbalance.

Research focusing on this component and similar derivatives research examined observational settings and through mechanism studies involving patients with elevated lipid levels or those with fatty liver concerns. The evidence for this supportive function is more mechanistic than the appetite stimulation research. Findings indicate patterns related to metabolic effects, but research on the specific contribution of this component when used in the Tricol combination remains insufficient.


Research on Long-Term Outcomes and Follow-Up

The majority of clinical trials conducted on the active components of Tricol were designed as short-term studies, often observing responses over defined time intervals lasting between four and twelve weeks. Consequently, long-term effects are not fully established.

Key Studies & References

  1. Cyproheptadine as an appetite stimulant in children. Is it safe?
  2. Cyproheptadine in anorexia nervosa
  3. Tricholine Citrate: View Uses, Side Effects and Medicines
  4. Bile acid sequestrant - Mechanism of Action and Medical Uses

Frequently Asked Questions (FAQ)

Common questions about Tricol (FAQ)

Q: Can Tricol cause weight gain?

A: Studies have examined the appetite-stimulating component of Tricol (Cyproheptadine) and reported documented measurements of short-term weight change and shifts in patient-reported appetite scores. These findings were observed primarily in studies of pediatric patients. The official literature describes these findings in the context of the medicine’s primary intended use.


Q: Is it safe to drink alcohol while using Tricol?

A: Regulatory documents describe an additive effect when Tricol is used with alcohol and other Central Nervous System (CNS) depressants. This combination may result in enhanced CNS depression, such as increased drowsiness. The official safety information describes the characteristics of this interaction.


Q: Will taking Tricol affect my ability to drive or operate machinery?

A: Due to the antihistamine component, Tricol can cause side effects like drowsiness and dizziness. Official safety warnings indicate that caution is required or that driving and operating machinery should be avoided while experiencing these effects.


Q: How long can a person safely stay on Tricol therapy?

A: Official information indicates that the majority of clinical trials conducted on the active components of Tricol were designed as short-term studies, often lasting between four and twelve weeks. Consequently, the long-term effects are not fully established in regulatory documents.


Q: Are there any specific foods I need to avoid when taking Tricol?

A: According to the official product label, there are no known interactions with common food or drinks. The medicine offers flexibility and may be taken with or without food, as determined by a healthcare professional.


Q: What are the most commonly reported side effects of Tricol?

A: Side effects are often mild and related to the medicine's antihistamine component. The official label lists common effects, including drowsiness, dizziness, dry mouth, blurred vision, nervousness, and insomnia. These are among the effects most commonly cited in regulatory documents.


Q: Can Tricol interact with herbal supplements like St. John's Wort?

A: Tricol's primary component has effects on the Central Nervous System (CNS). While a specific interaction with St. John's Wort may not be explicitly listed in the core prescribing label, regulatory documents advise caution when combining Tricol with other agents that affect the Central Nervous System.


Q: Is Tricol approved for use in countries outside of the US?

A: Formulations containing the active components of Tricol (Cyproheptadine and Tricholine Citrate) are widely recognized. They are sold under various regulatory approvals in many countries globally, indicating its status as a widely recognized medicinal formulation.


Q: What is the difference between Tricol and its generic version?

A: Regulatory policy requires the active ingredients and their therapeutic effect to be identical between the brand name (Tricol) and its generic version. Differences usually involve the inactive ingredients, such as the dyes, binders, flavors, or fillers used in the formulation.


Q: Can the effectiveness of Tricol be reduced by other medications?

A: Official documents note a specific restriction regarding Metyrapone. Co-administration is contraindicated because the active substance of Tricol is documented to decrease the therapeutic effects of Metyrapone.


Q: Do the official guidelines suggest any routine monitoring while taking Tricol?

A: Dosage is individualized based on patient need and response. Caution is required for patients with renal or hepatic impairment. This generally suggests the need for ongoing professional monitoring of health status and potential dosage adjustment.


Q: How do studies describe Tricol's impact on mood?

A: The official side effect list includes Central Nervous System (CNS) effects such as nervousness and insomnia, which are related to the central action of the antihistamine component. Specific, focused descriptions of general 'mood impact' are not typically detailed in product labels.


Q: Can I take Tricol with my morning coffee?

A: The official label notes no known interactions with common food or drinks. Coffee is generally covered under this guidance. Patients may take the medicine with or without food.


Q: Is Tricol a brand-name or a generic medicine?

A: Tricol is a prescription-only, combination drug that is typically marketed as a brand name formulation containing generic active components.


Q: Why do some people say Tricol made them feel tired?

A: The key component, Cyproheptadine, is a first-generation antihistamine. This class of medicine is known to easily cross into the central nervous system, which is the mechanism that causes the common side effect of drowsiness (tiredness).


Q: Is Tricol known to cause any long-term health issues?

A: The majority of clinical trials were designed as short-term studies (four to twelve weeks). The lack of long-term trial data means information on potential long-term health issues is not established in regulatory documents.


Q: Does Tricol commonly cause dizziness or lightheadedness?

A: Yes, the official side effect list includes dizziness and lightheadedness as common side effects. These are related to the Central Nervous System effects of the antihistamine component of the medicine.


Q: What evidence is there that Tricol helps with the long-term management of the condition?

A: Research evidence indicates that the majority of clinical trials conducted on the active components of Tricol were designed as short-term studies. Consequently, the long-term effects are not fully established, meaning the evidence focuses on short-term outcomes.


Q: What is the main purpose of the 'inactive ingredients' in a Tricol tablet?

A: Inactive ingredients, such as Sorbitol, are used for functional roles. These functions include providing gentle digestive comfort (as an osmotic agent), serving as the aqueous solution base, and ensuring the overall stability and form of the product.


Q: Is the benefit of Tricol consistent across all patient populations studied?

A: Research evidence indicates that findings were mixed across different study populations. This suggests that the observed benefit was not consistent in every group examined in the clinical studies.


Q: Can people who are lactose intolerant use Tricol?

A: Tricol is formulated as an oral solution or syrup. The official inactive ingredient list can be consulted for the presence of lactose. Lactose is typically only found in the inactive ingredients of solid dosage forms (tablets/capsules).


Q: How quickly should I start feeling the effects of Tricol?

A: The medicine is intended for gradual nutritional and metabolic support. Official information indicates that the onset of action may require a few weeks for the intended effect to be realized, as immediate, rapid effects are not typically expected or noted.


Q: What happens if I miss taking a dose of Tricol?

A: Official guidelines typically advise to administer the missed dose as soon as possible if there is still enough time before the next scheduled dose. If it is almost time for the next dose, the guidance is often to skip the missed dose and take the next dose at the regular time.


Q: What is the typical time frame for Tricol to reach its full effectiveness?

A: The typical time frame for the medicine to reach its full intended effect is often described as requiring a few weeks to be realized. This reflects the gradual nature of its nutritional and metabolic effects.


Q: Is it normal to feel a mild stomach upset when first starting Tricol?

A: The official side effect list includes stomach upset (nausea, vomiting, stomach upset) under the Gastrointestinal system. This means it is a known, reported effect of the medicine that patients may experience, especially when first starting.


Q: Can Tricol be crushed or split if a person has trouble swallowing?

A: Tricol is formulated as an oral solution or syrup, not a solid dose form. The administration requirements mandate that the volume must be drawn using a specialized medical measuring device to ensure dosing accuracy.


Q: Are there any lifestyle changes suggested by official sources to support Tricol treatment?

A: Official patient information often mentions general suggestions that may support the treatment's goal of improving nutritional intake. These may include suggestions for consuming calorie-containing beverages or adjusting eating habits to aid in better overall intake.


Q: Are there specific age groups that should not use Tricol?

A: Yes, official regulatory documents define specific populations that must not use this medicine. It is contraindicated for newborn or premature infants and elderly or debilitated patients. Safety and effectiveness have also not been established for children under two years of age.

How should Tricol be stored and disposed of?

How to Store and Dispose of Tricol?

This oral solution must be stored strictly according to regulatory specifications to maintain its stability.

Storage Requirements

Tricol must be kept in its original container with the cap tightly closed and stored protected from light. The required storage condition is a cool and dry place at a temperature not exceeding 30°C. It is mandatory to keep this medicine out of the sight and reach of children.

Disposal Instructions

Do not use Tricol after the expiry date. Unused or expired medicine should not be thrown away in household waste or flushed down a sink or toilet (wastewater). The official guidance recommends utilizing a drug take-back program or consulting a pharmacist for appropriate disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tricol found in:

A-Z Index: